• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I STAT HIGH SENSITIVITY TROPONIN-I; IMMUNOASSAY METHOD, TROPONIN SUBUNIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I STAT HIGH SENSITIVITY TROPONIN-I; IMMUNOASSAY METHOD, TROPONIN SUBUNIT Back to Search Results
Catalog Number 04Z21-25
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/26/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Complete entry for section a1 - patient identifier: (b)(6).Complete entry for section a2 - age at time of event, a2 - age units (patient) and a3a - sex: 67-year-old female, 52-year-old male.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event or Problem Description
The customer observed falsely elevated alinity i stat high sensitivity troponin-i for two patients.The following results were provided: customer normal range
 
Additional Manufacturer Narrative
A complaint investigation was conducted for the alinity i stat high sensitivity troponin-i reagent lot 77410ud00.A review of tracking and trending did identify an increase in complaint activity.However, no commonalities for the complaint lot and issue were identified.Accuracy testing was completed using panels which mimic patient samples using an in-house retained kit of lot 77410ud00.All specifications were met indicating that the lot is performing acceptably.Device history review did not identify issues associated with the customer¿s observation.Labeling review concludes that the issue is adequately addressed.Based on our investigation, no systemic issue or deficiency was identified with the alinity i stat high sensitivity troponin-i reagent, lot number 77410ud00.
 
Event or Problem Description
The customer observed falsely elevated alinity i stat high sensitivity troponin-i for two patients.The following results were provided: customer normal range
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I STAT HIGH SENSITIVITY TROPONIN-I
Common Device Name
IMMUNOASSAY METHOD, TROPONIN SUBUNIT
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key23617960
Report Number3005094123-2025-00593
Device Sequence Number15975227
Product Code MMI
UDI-Device Identifier00380740194062
UDI-Public(01)00380740194062(17)251217(10)77410UD00
Combination Product (Y/N)N
Initial Reporter StateWV
Initial Reporter CountryUS
PMA/510(K) Number
K202525
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/17/2025
Device Catalogue Number04Z21-25
Device Lot Number77410UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/04/2025
Supplement Date Received by Manufacturer12/10/2025
Initial Report FDA Received Date11/21/2025
Supplement Report FDA Received Date12/10/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/02/2025
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALNTY I PROCESSING MODU, 03R65-01, (B)(6).; ALNTY I PROCESSING MODU, 03R65-01, (B)(6).
Patient Age67 YR
Patient SexFemale
-
-